Related Experiment Video
Updated: May 30, 2026
08:54
Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
Published on: February 14, 2018
Antifungal therapy
1Supportive Care, Radboud University Medical Centre, Nijmegen, The Netherlands. be.depauw@yahoo.com
Transplantation Proceedings
|August 16, 2011
Summary
Managing fungal diseases presents significant challenges, impacting clinical study reliability. This review explores current difficulties, recent advancements, and future directions in fungal disease management.
Area of Science:
- Mycology
- Infectious Diseases
- Clinical Research
Background:
- Fungal infections pose a significant global health burden.
- Current treatment strategies for fungal diseases face limitations.
- Reliability of clinical trial data in mycology is often compromised.
Purpose of the Study:
- To discuss the challenges in managing fungal diseases.
- To review recent advancements in the field of mycology.
- To present potential future developments in antifungal therapies and diagnostics.
Main Methods:
- Literature review of current challenges in fungal disease management.
- Synthesis of recent improvements in antifungal treatments and diagnostics.
- Exploration of emerging trends and future research directions.
Main Results:
- Identified key difficulties in clinical studies of fungal infections.
- Highlighted recent breakthroughs in antifungal drug development and therapeutic approaches.
- Outlined promising avenues for future research and clinical application.
Conclusions:
- Addressing current management challenges is crucial for improving patient outcomes.
- Recent innovations offer new hope for more effective fungal disease control.
- Continued research is essential to overcome the complexities of fungal infections.
Related Concept Videos
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:20Candidiasis
Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications